Tout DSpace

Parcourir par sujet "adenoidectomy"

Voici les éléments 1-7 de 7

    • Adenotonsillectomy Outcomes in Treatment of Obstructive Sleep Apnea in Children A Multicenter Retrospective Study 

      Bhattacharjee, R.; Kheirandish-Gozal, L.; Spruyt, K.; Mitchell, R. B.; Promchiarak, J.; Simakajornboon, N.; Kaditis, A. G.; Splaingard, D.; Splaingard, M.; Brooks, L. J.; Marcus, C. L.; Sin, S.; Arens, R.; Verhulst, S. L.; Gozal, D. (2010)
      Rationale: The overall efficacy of adenotonsillectomy (AT) in treatment of obstructive sleep apnea syndrome (OSAS) in children is unknown. Although success rates are likely lower than previously estimated, factors that ...

    • Adenotonsillectomy to treat obstructive sleep apnea: Is it enough? 

      Boudewyns A., Abel F., Alexopoulos E., Evangelisti M., Kaditis A., Miano S., Villa M.P., Verhulst S.L. (2017)
      Although adenotonsillectomy is the first line treatment for children with obstructive sleep apnea syndrome (0SAS),1 improvement in objectively documented outcomes is often inadequate and a substantial number of children ...

    • C-reactive protein as a potential biomarker of residual obstructive sleep apnea following adenotonsillectomy in children 

      Bhattacharjee R., Kheirandish-Gozal L., Kaditis A.G., Verhulst S.L., Gozal D. (2016)
      Study Objectives: Adenotonsillectomy (AT) is first-line treatment for pediatric obstructive sleep apnea (OSA), with most children having improvements in polysomnography (PSG). However, many children have residual OSA ...

    • ERS statement on obstructive sleep disordered breathing in 1- to 23-month-old children 

      Kaditis A.G., Alvarez M.L.A., Boudewyns A., Abel F., Alexopoulos E.I., Ersu R., Joosten K., Larramona H., Miano S., Narang I., Tan H.-L., Trang H., Tsaoussoglou M., Vandenbussche N., Villa M.P., Waardenburg D.V., Weber S., Verhulst S. (2017)
      The present statement was produced by a European Respiratory Society Task Force to summarise the evidence and current practice on the diagnosis and management of obstructive sleep disordered breathing (SDB) in children ...

    • Nasal corticosteroids for children with snoring 

      Alexopoulos, E. I.; Kaditis, A. G.; Kalampouka, E.; Kostadima, E.; Angelopoulos, N. V.; Mikraki, V.; Skenteris, N.; Gourgoulianis, K. (2004)
      Nasal corticosteroids improve polysomnography indices but not symptoms in children with mild to moderate sleep-disordered breathing. We hypothesized that administration of nasal corticosteroids for 4 weeks to snoring ...

    • Obstructive sleep disordered breathing in 2- to 18-year-old children: Diagnosis and management 

      Kaditis A.G., Alvarez M.L.A., Boudewyns A., Alexopoulos E.I., Ersu R., Joosten K., Larramona H., Miano S., Narang I., Trang H., Tsaoussoglou M., Vandenbussche N., Villa M.P., Waardenburg D.V., Weber S., Verhulst S. (2016)
      This document summarises the conclusions of a European Respiratory Society Task Force on the diagnosis and management of obstructive sleep disordered breathing (SDB) in childhood and refers to children aged 2-18 years. ...

    • Urine concentrations changes of cysteinyl leukotrienes in non-obese children with obstructive sleep apnea undergoing adenotonsillectomy 

      Mousailidis G., Lachanas V.A., Vasdeki A., Alexopoulos E.I., Kaditis A.G., Petinaki E., Balatsos N., Bizakis J.G., Skoulakis C.E. (2018)
      Objective: The main objective of the study was to compare preoperative to postoperative levels of urine-Cysteinyl leukotrienes (uCysLT) in children undergoing adenotonsillectomy (AT) for obstructive sleep apnea (OSA) in ...